GSEA enrichment analysis revealed that many signaling pathways were significantly enriched in the high-risk subgroup, including pathways related to metabolism and metabolic diseases, such as pyruvate metabolism, glycolysis gluconeogenesis, and insulin signaling pathways. This evidence concerns the gene INS and Other metabolic disease.